Intermittent Fasting: Methods and Benefits

What Is Intermittent Fasting?

Intermittent fasting (IF) is an umbrella term for eating patterns that cycle between defined periods of fasting and eating. Unlike conventional diets that specify what to eat, intermittent fasting focuses primarily on when to eat. During fasting windows, energy intake is either zero or very limited (typically below 500 kcal on modified fasting days).

Interest in intermittent fasting has grown substantially over the past two decades, driven by animal research suggesting metabolic benefits beyond simple calorie restriction, and by the practical appeal of a simple rule-based approach to managing food intake.

Popular Intermittent Fasting Protocols

Several distinct IF protocols have been studied and widely adopted:

The 16:8 protocol is the most widely practiced. A typical implementation skips breakfast, eats the first meal around noon, and finishes eating by 8 p.m. Coffee, tea, and water do not break a fast in most definitions.

Metabolic Effects of Fasting

The physiological changes during a fast occur in a predictable sequence:

• 0–4 hours (fed state): Digestion and nutrient absorption. Insulin rises; glucose and fatty acids are stored.
• 4–16 hours (post-absorptive): Blood glucose and insulin fall. The liver releases glucose from glycogen stores. Fat oxidation begins to increase.
• 16–24 hours (early fasting): Glycogen stores are largely depleted. Gluconeogenesis (production of glucose from amino acids and glycerol) increases. Ketone production begins in earnest.
• 24–72 hours (extended fasting): Ketosis deepens. Growth hormone secretion increases. Autophagy — cellular "self-cleaning" — is upregulated, particularly in liver and muscle cells.

For most IF protocols of 16–24 hours, the primary metabolic effects are insulin reduction and a modest increase in fat oxidation, rather than deep ketosis or substantial autophagy.

Evidence on Weight Loss and Health Markers

Research findings on intermittent fasting present a nuanced picture:

• Weight loss: IF produces weight loss roughly equivalent to continuous calorie restriction when total calorie intake is matched. A 2022 NEJM study comparing 16:8 TRE to unrestricted eating found similar weight loss (~8 kg over 12 months) with no significant difference from continuous energy restriction in most trials.
• Insulin sensitivity: Multiple studies show reduced fasting insulin and improved HOMA-IR (a measure of insulin resistance) with IF, though effects are often comparable to general weight loss.
• Lipid profile: IF is associated with modest reductions in triglycerides (8–12 %) and LDL in some studies; HDL effects are variable.
• Cardiovascular risk: A 2024 American Heart Association observational study of 20,000 adults found that 8-hour time-restricted eating was associated with 91 % higher risk of cardiovascular death compared to a 12–16 hour window, though the observational design limits causal conclusions.
• Muscle mass: Short-term IF with adequate protein intake (≥ 1.2 g/kg body weight) appears to preserve lean mass during weight loss.

Who Should Be Cautious

Intermittent fasting is not appropriate for everyone. Caution or medical supervision is advised for:

• People with type 1 diabetes or insulin-dependent type 2 diabetes (hypoglycemia risk)
• Those with a history of eating disorders
• Pregnant or breastfeeding women
• Children and adolescents
• Individuals who are underweight (BMI < 18.5)
• People taking medications that require food (e.g., metformin, aspirin)

Common side effects during the adaptation period (1–2 weeks) include hunger, headaches, difficulty concentrating, and irritability. These typically subside as the body adapts to the fasting schedule. Staying well-hydrated and maintaining adequate electrolyte intake can ease the transition.